Search Within

Han Xiao

Formats
  1. Meeting Abstract (32)
  2. Journal Article (26)
  3. Book Section (1)
Groups
  1. Department of Medicine (59)
  2. Genitourinary Oncology Service (59)
  3. Solid Tumor Oncology Division (59)
  4. Epidemiology and Biostatistics (21)
  5. Survivorship Research (20)
  6. Biostatistics Service (16)

More Groups

People
  1. Eric Sherman (13)
  2. David Pfister (12)
  3. Matthew Fury (11)
  4. Sofia Haque (10)
  5. Alan Ho (9)
  6. Dean Bajorin (9)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Oncology (5)
  3. Cancer (3)
  4. Head & Neck (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Atlas of Genitourinary Oncological Imaging (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Oxford University Press (6)
  3. Wiley Blackwell (3)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding interest, barriers, and preferences related to yoga practice among cancer survivors
    Journal Article

    Desai, K.; Bao, T.; Li, Q. S.; Raghunathan, N. J.; Trevino, K.; Green, A.; Xiao, H.; Mao, J. J.
    Supportive Care in Cancer (2021)

    Fulltext@MSK | Save
  • Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma
    Meeting Abstract

    Teo, M. Y.; Ratna, N.; Regazzi, A. M.; Zimmerman, D. E.; McHugh, D. J.; Laccetti, A. L.; Xiao, H.; Lee, C. H.; Aggen, D. H.; Funt, S. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Implementation of Symptom Care Clinic (SCC) for acute symptoms management at outpatient oncology ambulatory centers
    Meeting Abstract

    Xiao, H.; Fahy, R.; Salvaggio, R.; OSullivan, M.; Sokoli, D.; Murray, C.; Majeed, J.; Mao, J. J.; Groeger, J. S.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Panageas, K.; Baser, R. E.; Romero, S. A. D.; Li, Q. S.; Xiao, H.; Bao, T.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Building a clinically relevant risk model: Predicting risk of a potentially preventable acute care visit for patients starting antineoplastic treatment
    Journal Article

    Daly, B.; Gorenshteyn, D.; Nicholas, K. J.; Zervoudakis, A.; Sokolowski, S.; Perry, C. E.; Gazit, L.; Baldwin Medsker, A.; Salvaggio, R.; Adams, L.; more...
    JCO Clinical Cancer Informatics (2020)

    Fulltext@MSK | Save
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Heller, G.; Bryce, A. H.; Armstrong, A. J.; Beltran, H.; Hahn, O. M.; McGary, E. C.; Mehan, P. T.; Goldkorn, A.; Roth, B. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients
    Meeting Abstract

    McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Paller, C. J.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W. D.; Den, R. B.; Deville, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A framework for building a clinically relevant risk model
    Meeting Abstract

    Daly, R. M.; Gorenshteyn, D.; Gazit, L.; Sokolowski, S.; Nicholas, K.; Perry, C.; Adams, L.; Baldwin, A.; Holland, J. C.; Zervoudakis, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save